Abstract
Several lines of evidence support a mutual relationship between the nervous system and the immune system. Therefore, it is not surprising that some neuropsychiatric disorders are also characterized by immune abnormalities. In patients with phobic disorders and in patients with migraine without aura some common immune abnormalities have been detected and, in particular, natural immunity deficits, exaggerated release of proinflammatory cytokines and circulating bacterial endotoxins have been found. In other neurological disease, some etiologic factors have been detected as in the case of Guillain-Barrè syndrome in which molecular mimicry between Campylobacter jejuni endotoxin and GM1 ganglioside may cause an acute inflammatory polyneuropathy. On the other hand, attempts to identify an antigen have been made in patients with Alzheimers disease and schizophrenia. Finally, the chronic fatigue syndrome, an old illness in search for an antigen, risk factors and precipitating agents have been described but evidence for a specific antigen is still lacking.
Keywords: alzeihmer, aids dementia complex, migraine, phobic disorders, schizophrenia, chronic fatigue syndrome, microglia, astrocytes
Current Pharmaceutical Design
Title: A Point of View: The Need to Identify an Antigen in Psyconeuroimmunological Disorders
Volume: 9 Issue: 24
Author(s): V. Covelli, N. M. Pellegrino and E. Jirillo
Affiliation:
Keywords: alzeihmer, aids dementia complex, migraine, phobic disorders, schizophrenia, chronic fatigue syndrome, microglia, astrocytes
Abstract: Several lines of evidence support a mutual relationship between the nervous system and the immune system. Therefore, it is not surprising that some neuropsychiatric disorders are also characterized by immune abnormalities. In patients with phobic disorders and in patients with migraine without aura some common immune abnormalities have been detected and, in particular, natural immunity deficits, exaggerated release of proinflammatory cytokines and circulating bacterial endotoxins have been found. In other neurological disease, some etiologic factors have been detected as in the case of Guillain-Barrè syndrome in which molecular mimicry between Campylobacter jejuni endotoxin and GM1 ganglioside may cause an acute inflammatory polyneuropathy. On the other hand, attempts to identify an antigen have been made in patients with Alzheimers disease and schizophrenia. Finally, the chronic fatigue syndrome, an old illness in search for an antigen, risk factors and precipitating agents have been described but evidence for a specific antigen is still lacking.
Export Options
About this article
Cite this article as:
Covelli V., Pellegrino M. N. and Jirillo E., A Point of View: The Need to Identify an Antigen in Psyconeuroimmunological Disorders, Current Pharmaceutical Design 2003; 9 (24) . https://dx.doi.org/10.2174/1381612033454234
DOI https://dx.doi.org/10.2174/1381612033454234 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Tuberculosis Vaccines: Hopes and Hurdles
Infectious Disorders - Drug Targets Biology of gama delta T Cells in Tuberculosis and Malaria
Current Molecular Medicine Dementia Etiologies and Remedies in Traditional Persian Medicine; A Review of Medicinal Plants and Phytochemistry
Current Drug Metabolism Neurotuberculosis: An Overview
Central Nervous System Agents in Medicinal Chemistry Micronutrients at the Interface Between Inflammation and Infection Ascorbic Acid and Calciferol. Part 1: General Overview with a Focus on Ascorbic Acid
Inflammation & Allergy - Drug Targets (Discontinued) Registered and Investigational Drugs for the Treatment of Methicillin-Resistant Staphylococcus aureus Infection
Recent Patents on Anti-Infective Drug Discovery Advances in TB Vaccinology
Current Respiratory Medicine Reviews New Strategies and Patent Therapeutics in EBV-Associated Diseases
Mini-Reviews in Medicinal Chemistry Neurotransmitter Effects in Human Immunodeficiency Virus (HIV) and Simian Immuno-Deficiency Virus (SIV) Infection
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Human Anthrax as a Re-Emerging Disease
Recent Patents on Anti-Infective Drug Discovery The Formulation of Lipid-Based Nanotechnologies for the Delivery of Fixed Dose Anticancer Drug Combinations
Current Drug Delivery Blood-Brain Barrier Transport of Short Proline-Rich Antimicrobial Peptides
Protein & Peptide Letters Clinical Potential of Neuropeptide Y Receptor Ligands in the Treatment of Epilepsy
Current Topics in Medicinal Chemistry Intestinal Barrier Dysfunction Participates in the Pathophysiology of Ischemic Stroke
CNS & Neurological Disorders - Drug Targets Cell Microencapsulation Implants into the Central Nervous System
Recent Patents on Nanomedicine Intracranial Non-traumatic Aneurysms in Children and Adolescents
Current Pediatric Reviews Adjunctive Immunotherapy of Mycobacterial Infections
Current Pharmaceutical Design Improving the Stability of Aptamers by Chemical Modification
Current Medicinal Chemistry New Agents to Treat Life-Threatening Fungal Infections
Current Topics in Medicinal Chemistry Update on the Development of TB Vaccines
Current Pharmaceutical Biotechnology